Clinical Trial Update: Atrasentan in Treating Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating atrasentan for prostate cancer, sponsored by Abbott.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Atrasentan (atrasentan)

Snippet

Sponsor: Abbott | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED